Bayer AG, whose name is usually associated with aspirin, has signaled its intention to deepen its commitment to crop science by raising its takeover bid for Monsanto Inc to $125 per share. The move values the company at $64 billion. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
